Generic DuoNeb

From WikiCover

Jump to: navigation, search

On January 2, 2008, Watson Pharmaceuticals announced that it has received final approval from the FDA on its Abbreviated New Drug Application (ANDA) for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution in the 0.5 mg/3 mg strength.

Watson's Ipratropium Bromide and Albuterol Sulfate product is the generic equivalent to Dey, L.P.'s DuoNeb, which is indicated for the treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) in patients requiring more than one bronchodilator.

Watson intends to launch its Ipratropium Bromide and Albuterol Sulfate product immediately.

Name (required):

Comment:

Retrieved from "http://www.wikicover.com/Generic_DuoNeb"